Skip to content

News

What covered companies filed with the SEC, day by day.

  1. 25
  2. 26
  3. 29
  4. 30
  5. 1
  6. 2
  7. 6
  8. 7
  9. 8
‹ Tue, Jul 7, 2009

Wednesday, July 8, 2009

111 filings · 87 companiesAll checks passed · Updated Nov 5

Thu, Jul 9, 2009 ›
The dayWednesday, July 8

By time of day

32 filings
Each bar is 30 minutes, New York time. Select one to filter the filings below.
  • Results
  • Other filings

2 without a time on file

Results

1 announced

After-hours1

  • 17:28SCSCScansource, Inc.

Reports

1 quarterly · 1 annual
  1. Arts WAY Manufacturing Co IncARTW · 10-Q · May 31 · 15:12
    ——
  2. Vivakor, Inc.VIVK · 10-K · Dec 31 · 17:05
    ——

Insiders

8 filings
Purchases$0.000 filings
Sales$20.25M8 filings
SFDSmithfield Foods Inc · Joseph W Luter III, Director$10.55MSale · 800,000 sh
CPRTCopart Inc · Thomas W Smith, Director$6.12MSale · 185,763 sh
RGENRepligen Corp · Biotechnology Value Fund L P$2.49MSale · 451,800 sh
PLXProtalix BioTherapeutics, Inc. · Yoseph Shaaltiel, Executive VP, R&D$509.40KSale · 100,000 sh
PLXProtalix BioTherapeutics, Inc. · Einat Brill Almon, VP, Product Development$280.17KSale · 55,000 sh
PLXProtalix BioTherapeutics, Inc. · Yossi Maimon, VP, Chief Financial Officer$255.30KSale · 50,000 sh
Open insider activity

Filings

32 listed

17:00

  1. 17:33

21:00

  1. 21:32

22:00

  1. 22:14

08:00

  1. 08:43

10:00

  1. 10:00
  2. 10:30
  3. 10:31
  4. 10:52

11:00

  1. 11:54

13:00

  1. 13:25

15:00

  1. 15:12
  2. 15:24

16:00

  1. 16:12
  2. 16:15
  3. 16:19
  4. 16:40
  5. 16:43

17:00

  1. 17:00
  2. 17:03
  3. 17:04
  4. 17:05
  5. 17:17
  6. 17:19
  7. 17:24
  8. 17:28

20:00

  1. 20:20
  2. 20:37

21:00

  1. 21:23
  2. 21:26
  3. 21:27

—

  1. —
  2. —
32 of 32

Index

Forms filed

  • Current report8-K23
  • Insider filing422
  • Foreign issuer report6-K18
  • 40-APP/A8
  • N-CSRS8
  • CORRESP5
  • UPLOAD5
  • Stake reportedSC 13D4
  • Initial ownership32
  • Stake amendedSC 13D/A2
  • Annual report10-K1
  • Quarterly report10-Q1
  • 13F-NT1
  • Prospectus supplement424B31
  • Prospectus424B41
  • Annual report to shareholdersARS1
  • Proxy statementDEF 14A1
  • Proxy materialDEFA14A1
  • EFFECT1
  • NSAR-A1
  • Preliminary proxy statementPRE 14A1
  • RW1
  • Amended shelf registrationS-3/A1
  • S-3ASR1